AD is common and debilitating chronic inflammatory disease. Its treatment is aimed at continuous epidermal-barrier repair. Though widely studied safe, targeted treatment options are currently limited.
This e-learning module provides a brief review on the approach to non-melanoma and melanoma skin cancer.